Search

Search Results

• 

  Factor XI inhibitors in adjunct to antiplatelet therapy: the ultimate dual-pathway inhibition?

  Mattia Galli, C. Michael Gibson, Dominick J. Angiolillo

  03-08-2023

  Published: 3 August 2023

  1173

  PDF: 408
• 

  Risk of recurrent venous thromboembolism in cancer patients after discontinuation of anticoagulant therapy

  Gary E. Raskob

  16-05-2024

  Published: 16 May 2024

  318

  PDF: 153
• 

  Antithrombotic therapy in idiopathic infertility

  Fabio Tumminello, Silvia Cardi, Corrado Lodigiani, Maria Elisa Mancuso

  03-10-2024

  Published: 3 October 2024

  1179

  PDF: 234

• The evolving landscape of gene therapy for congenital severe hemophilia: a 2024 state of the art

  Giovanni Di Minno, Gaia Spadarella, Ilenia Lorenza Calcaterra, Giancarlo Castaman, Paolo Simioni, Raimondo De Cristofaro, Cristina Santoro, Flora Peyvandi, Matteo Di Minno

  04-09-2024

  Published: 4 September 2024

  524

  PDF: 113

  SUPPLEMENTARY MATERIAL: 78
• 

  Guided antiplatelet therapy in patients undergoing percutaneous coronary intervention

  Marco Cattaneo

  23-06-2023

  Published: 23 June 2023

  921

  PDF: 165
• 

  Venous thromboembolism treatment in patients with cancer: reflections on an evolving landscape

  Agnes Y.Y. Lee

  29-02-2024

  Published: 29 February 2024

  1245

  PDF: 209
• 

  Combined oral contraceptives and the risk of venous thromboembolism carriers of antithrombin, protein C or S deficiency: Sub-analysis of a prospective cohort study

  Daniela Tormene, Elena Campello, Chiara Simion, Anna Poretto, Paolo Prandoni, Paolo Simioni

  03-11-2022

  Published: 3 November 2022

  729

  PDF: 238

• Tailored therapy with turoctocog alfa pegol according to patient’s lifestyle and hemorrhagic phenotype: from clinical trial to real-life

  Ilaria Nichele, Giuseppe Carli, Alberto Tosetto

  22-04-2024

  Published: 22 April 2024

  255

  PDF: 56

• Commentary on “Preventive percutaneous coronary intervention versus optimal medical therapy alone for the treatment of vulnerable atherosclerotic coronary plaques (PREVENT): a multicenter, open-label, randomized controlled trial”

  Ottavia Borghese, Claudio Vincenzoni

  26-06-2024

  Published: 26 June 2024

  867

  PDF: 205
• 

  Pleiotropic effects of anti-thrombotic therapies: have direct oral anticoagulants any anti-inflammatory effect?

  Anna Maria Gori, Eleonora Camilleri, Alessia Bertelli, Angela Rogolino, Francesca Cesari, Elena Lotti, Tommaso Capobianco, Walther Iannotti, Betti Giusti , Rossella Marcucci

  14-12-2022

  Published: 14 December 2022

  656

  PDF: 282
• 

  Successful treatment of aortic arch mural thrombosis with low-dose, ultra-slow-flow thrombolysis: a case report and literature review

  Rosina Albisinni, Tommaso Marrazzo, Arta Karruli, Sabrina Manduca, Giuseppe Nobile, Nicola Galdieri, Marisa De Feo

  24-10-2022

  Published: 24 October 2022

  444

  PDF: 157
• 

  Management of anticoagulation in atrial fibrillation patients in Italy: insight from the Atrial Fibrillation-Survey on Anticoagulated Patients Register (AF-START)

  Daniela Poli, Walter Ageno, Emilia Antonucci, Salvatore Bradamante, Eugenio Bucherini, Paolo Chiarugi, Antonio Chistolini, Benilde Cosmi, Anna Falanga, Antonio Insana, Domenico Lione, Rosa Maria Lombardi, Giuseppe Malcangi, Rossella Marcucci, Giuliana Martini, Lucilla Masciocco, Carmelo Paparo, Daniele Pastori, Simona Pedrini, Vittorio Pengo, Pasquale Pignatelli, Andrea Toma, Sophie Testa, Gualtiero Palareti

  27-06-2023

  Published: 27 June 2023

  1043

  PDF: 236

  Supplementary File: 111
• 

  Trends and updates on the epidemiology of cancer-associated thrombosis: a systematic review

  Ang Li, Emily Zhou

  16-05-2024

  Published: 16 May 2024

  437

  PDF: 165
• 

  New perspectives for prevention of the post-thrombotic syndrome

  Paolo Prandoni

  22-03-2022

  Published: 22 March 2022

  1279

  PDF: 412
• 

  Growing weapons to fight hemophilia

  Pier Mannuccio Mannucci

  23-02-2023

  Published: 23 February 2023

  633

  PDF: 272
• 

  How to manage antithrombotic treatments in thrombocytopenic patients with cancer. Comments on the European Haematology Association guidelines

  Anna Falanga, Hugo Ten Cate, Bianca Rocca

  27-01-2023

  Published: 27 January 2023

  549

  PDF: 259
• 

  Polycythemia vera and management of the thrombotic risk: an update

  Massimo Franchini

  20-12-2023

  Published: 20 December 2023

  1710

  PDF: 223
• 

  A case of acquired factor XIII deficiency secondary to plasmablastic lymphoma

  Vincenzo Sammartano, Adele Santoni, Elisabetta Zappone, Paola Calzoni, Daniela Fineschi, Eleonora Franceschini, Federico Caroni, Anna Sicuranza, Monica Bocchia, Luca Puccetti

  09-03-2023

  Published: 9 March 2023

  516

  PDF: 317
• 

  Allopurinol-induced acquired von Willebrand syndrome

  Juan Eirís, Marina Suárez-Terrón, Pablo Granados, David Martínez-Campuzano, Ana Rosa Cid, Saturnino Haya, Santiago Bonanad

  25-10-2023

  Published: 25 October 2023

  1461

  PDF: 143